Coronavirus Vaccine – Clinical Trials, Treatment & Progress
Coronavirus vaccine samples are being tested on animals and humans. Cutting-edge drugs are being developed to stop the pandemic.
Coronavirus spread across the world is increasing with unseen speed and brutality. It has forced us to cancel some of the major events like the Tokyo Olympics and sent almost every one of us into self-quarantine in an attempt to prevent the spread. Governments and health authorities are trying their best to flatten the curve and implement extensive measures to stop the viral spread in the community and researchers are turning their focus on finding a cure or vaccine to SARS-CoV-2.
Since SARS-CoV-2 was first identified as the causative agent for COVID-19, researchers are finding the facts about the genetic makeup of the virus and trying to unwind how to completely prevent the infections. There’s no cure to the actual virus but medical care professionals are just treating the symptoms. Many treatment options are being implemented and there are some old drugs, proving helpful. But there is more. A long-term strategy to prevent the COVID-19 outbreak is required and moreover, a vaccine is required.
Development of a new vaccine takes time and they need to rigorously tested for safety via clinical trials before they can try out on actual human beings. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases in the US, has mentioned many times that a vaccine for COVID-19 is at least 12 to 18 months away and experts agree to it.
What’s a COVID-19 Vaccine?
The COVID-19 pathogen i.e. SARS-CoV-2 is a family member of the Coronavirus family. The vaccine under development targets the pathogen in a unique manner.
Various organizations are right now working on a SARS-CoV-2 vaccine. These vaccines have a small piece of genetic code that acts as the antigen.
Major companies like Moderna are developing vaccines by taking a price of the genetic code for the S protein and mixing it with fatty nanoparticles that can be tested on humans. Inovio, a Pennsylvania biotech company is creating strands of DNA that can stimulate an immune response and Imperial College London is generating a similar vaccine using coronavirus’ genetic code. All these vaccines are created instantly but none of them are brought in the market.
Sanofi a French pharma giant together with Johnson & Johnson is working with the US Biomedical Advanced Research and Development Authority to create vaccines of their own.
Some organizations like Boston Children’s Hospital are trying different kinds of subsidiaries that can amplify the immune response. This way, according to the Harvard Gazette are targeting elderly who are not responding when vaccinated. It is estimated that using a mix of ingredients can supercharge their immunity. Research is still going on.
When will a vaccine be available?
Fauci posits that a vaccine is around 12 to 18 months away. “The good news is we did it more quickly than we’ve ever done it,” Fauci told 60 Minutes. (Note: 60 Minutes and CNET share a common parent company, ViacomCBS.) “The sobering news is that it’s not ready for prime time, for what we’re going through now.”